MentionFox
Home › funding signals › Cisterna Biologics
Accelerator · announced

Cisterna Biologics (YC S22) — High quality mRNA for therapeutic application

Cisterna Biologics appears in Y Combinator's company directory in the Summer 2022 batch, listed 2022-06-27. High quality mRNA for therapeutic application.

Just raised? Share it.

Cisterna Biologics: Accepted into Y Combinator Summer 2022

What do you want to do with Cisterna Biologics?

Cisterna Biologics

New accelerator entry · 2022-06-27 · the record

Summer 2022
batch
2
people
Early
stage
United States of America
region
Open the record →

In their words

Founded in 2022 and based in San Diego, California, Cisterna Biologics is a technology company. It aims to solve some of the challenges currently facing the biotech industry to develop mRNA-based therapeutics – quality, quantity, longevity and cost of mRNA. As mRNA technology matures, it becomes imperative that these issues are solved so we can fully explore mRNA's endless possibilities as a therapeutic. Cisterna uses proprietary technologies to either remove a contaminant at its source or replace the source itself. For example, to remove double-stranded RNA (dsRNA), we use ribozymes - molecular scissors - to precisely cut the mRNA at its 3’ end. This assures not only 3’ homogeneity, but also eliminates dsRNA, which are primarily produced due to self-templated additions at the 3’ end. Utilizing a PCR-like system to amplify the DNA template in large quantities eliminates the requirement for plasmid enrichment in bacteria, the prime source of endotoxin contamination. These are just a few examples of Cisterna’s powerful technologies being used to achieve our goal of 10x higher quality mRNA for therapeutic application.

What the record says

BatchSummer 2022
Announced2022-06-27
StageEarly
StatusActive
Team size2
IndustryHealthcare
Sub-industryHealthcare
SectorsSynthetic Biology, Biotech, Therapeutics
RegionsUnited States of America, America / Canada
BasedSan Diego, CA, USA
HiringNo
Sitehttp://www.cisternabx.com
Previously known asCisterna Biologics LLC, Cisterna Biologic

The full profile

Checking your access…

Is this you?

If you're behind Cisterna Biologics: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

Tools for this story

Each opens in a new tab, filled in for Cisterna Biologics. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-cisterna-biologics
Last updated 2026-09-26
Primary record: Y Combinator directory entry
Cisterna Biologics (YC S22) — High quality mRNA for therapeutic application. MentionFox, 2026-09-26. https://mentionfox.com/funding/yc-cisterna-biologics